XML 20 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Retained Earnings
Unearned ESOP Shares
Accumulated Other Comprehensive Income (Loss)
Cumulative-effect adjustment on the change in accounting for share-based payments
Cumulative-effect adjustment on the change in accounting for share-based payments
Retained Earnings
Beginning balance at Jun. 30, 2017 $ 397,647 $ 190 $ 213,459 $ 191,660 $ (7,935) $ 273 $ 680 $ 680
Beginning balance (in shares) at Jun. 30, 2017   18,967,875            
Increase (Decrease) in Stockholders' Equity                
Net income $ 8,235     8,235        
Granted restricted stock (in shares) 55,200              
Forfeited restricted stock (in shares)   (6,600)            
Retired stock $ (494)   (494)          
Retired stock (in shares)   (19,007)            
Exercised stock options 651 $ 1 650          
Exercised stock options (in shares)   44,200            
Stock option expense 1,758   1,758          
Restricted stock expense 1,269   1,269          
ESOP shares allocated 1,367   838   529      
Other comprehensive loss (1,871)         (1,871)    
Ending balance at Jun. 30, 2018 409,242 $ 191 217,480 200,575 (7,406) (1,598)    
Ending balance, shares (in shares) at Jun. 30, 2018   19,041,668            
Increase (Decrease) in Stockholders' Equity                
Net income 27,146     27,146        
Cash dividends declared on common stock, $0.27/common share (3,176)     (3,176)        
Stock repurchased $ (30,638) $ (11) (30,627)          
Stock repurchased (in shares)   (1,149,785)            
Granted restricted stock (in shares) 23,625              
Forfeited restricted stock (in shares)   (4,300)            
Retired stock $ (205)   (205)          
Retired stock (in shares)   (7,414)            
Exercised stock options 1,173 $ 0 1,173          
Exercised stock options (in shares)   80,311            
Stock option expense 736   736          
Restricted stock expense 865   865          
ESOP shares allocated 1,422   893   529      
Other comprehensive loss 2,331         2,331    
Ending balance at Jun. 30, 2019 $ 408,896 $ 180 190,315 224,545 (6,877) 733    
Ending balance, shares (in shares) at Jun. 30, 2019 17,984,105 17,984,105            
Increase (Decrease) in Stockholders' Equity                
Net income $ 22,783     22,783        
Cash dividends declared on common stock, $0.27/common share (4,552)     (4,552)        
Stock repurchased $ (24,484) $ (12) (24,472)          
Stock repurchased (in shares)   (1,114,094)            
Granted restricted stock (in shares) 56,306              
Forfeited restricted stock (in shares)   (3,400)            
Retired stock $ (222)   (222)          
Retired stock (in shares)   (8,474)            
Exercised stock options 1,541 $ 2 1,539          
Exercised stock options (in shares)   106,914            
Stock option expense 717   717          
Restricted stock expense 1,105   1,105          
ESOP shares allocated 1,195   666   529      
Other comprehensive loss 1,284         1,284    
Ending balance at Jun. 30, 2020 $ 408,263 $ 170 $ 169,648 $ 242,776 $ (6,348) $ 2,017    
Ending balance, shares (in shares) at Jun. 30, 2020 17,021,372 17,021,357